A Dangerous Bump

The autoimmune disease multiple sclerosis (MS) creates muscle control, vision, balance, and sensation problems for those who develop this disease. MS develops as the consequence of inflammation (called plaques) in various areas of the central nervous system, after which the protective coating of nerves, called the myelin sheath, is destroyed. Approximately 350,000 people in the…

The Female Side of HCV

The hepatitis C virus (HCV), while certainly an equal opportunity virus, presents some unique health risks for infected women. Let’s start with some good news for women: they are more likely to clear this virus than men, meaning that even if exposed to HCV, more women than men are able to fight off the virus…

The Scoop About Mavyret

Just two months ago, AbbVie’s Mavyret joined the ranks of treatments approved by the FDA for chronic infection of the hepatitis C virus (HCV). Hepatitis C continues to be a major public health issue, affecting nearly 4 million Americans. It’s a good time to review best practices with this newest HCV medication. The American Association…

Rapid HCV Tests Pay Off

By now, the message urging all Baby Boomers to get a one-time screening test for infection with the hepatitis C virus (HCV) has been heard. Yet HCV infections continue to occur at unsettling rates. New infections are being fueled by the ongoing epidemic of illegal drug use, particularly injection drugs. This is why a new…

Financial: Another Side Effect of Cancer Treatment

All too many cancer patients realize that the high cost of cancer treatment can end up as an unexpected side effect of treatment. In fact, some patients go into debt while trying to save their own life. This has become so common that it now has a name: financial toxicity. This economic hardship can be…

Curing Hepatitis C and Avoiding Liver Cancer

It’s a new era when it comes to chronic hepatitis C infection. Most Americans infected with the hepatitis C virus (HCV) will be treated with direct-acting antiviral medications and be cured of this disease. Achieving sustained viral response (SVR) – in other words being cured of this liver disease – has never been easier (in…

After Clearing the Virus

There are highly effective direct-acting antivirals that can cure chronic infection of the hepatitis C virus (HCV) for the majority of patients. However, it’s important for health care providers and their patients to understand that clearing this virus does not mean that no more care will be needed. There are some post-cure guidelines that should…

Patient Focus: Medication Safety in Natural Disasters

With Hurricane Harvey recovery efforts on everyone’s mind – as well as September being National Emergency Preparedness Month – this feels like the right time to share information about how to keep prescription medications safe during a natural disaster. Preparation begins, when possible, with planning ahead. When families gather bottled water and other essentials to…

Psoriasis Risks: More Than Skin Deep

The dry, scaly, and painful patches of skin typical of psoriasis afflict nearly 7.5 million Americans. This uncomfortable, chronic skin condition is most likely to develop on the joints, face, neck, trunk, arms, hands, feet, and scalp. Although a cure remains elusive, treatments are available to manage the symptoms. At first glance, some might assume…

Global Impact of Hepatitis

On a global level, viral hepatitis ranks in impact and seriousness as highly as HIV/AIDS, tuberculosis, and malaria. Yet, viral hepatitis receives less funding and attention from global health policy makers and donors than each of those other three diseases. It’s a surprising disconnect. For example, the UN’s Sustainable Development Goals set a goal to…

Adherence Remains a Core Issue

Medications generally sit at the heart of a care plan for those with a chronic disease, yet medication adherence by patients continues to be an ongoing concern. Estimates note that 75% of Americans are not taking their medication exactly as directed by their health care professional. Meanwhile, nonadherence aligns with poorer outcomes, as well as…

Is It Multiple Sclerosis?

Diagnosing multiple sclerosis (MS) can be trickier than one would think. There is not a single test that can be used by itself to rule in or rule out an MS diagnosis. Rather, an entire profile is developed based on medical history, a neurologic exam, and lab tests (including an MRI, evoked potentials, and spinal…

Even When Treatment Fails, There’s Still Hope

There has been – justifiably – so much good news about very effective treatments for chronic hepatitis C virus (HCV) infections that it’s easy to lose sight of the fact that not everyone is cured with these treatments. Yes, the sustained viral responses are incredibly high for most genotypes of infection. However, there are some…

Multiple Myeloma Patient Education Series (Part 5 of 5)

This summer I am sharing guest blogs from a variety of experts. This week’s blog is the fifth and final installment in a multi-part series about multiple myeloma from my colleague Dr. Margaret Henderson who has a Doctor of Pharmacy degree from the University of Colorado. –Dr. Stephen Vogt Welcome to the final part of…

Get Mobile to Save Time and Money

Health care is going mobile more than ever before and BioPlus is meeting this mobile challenge. By the end of this year, the mobile health app marketplace is expected to reach $26 billion as consumers increasingly turn to mobile application solutions to manage healthcare. Both patients and doctors are on-board with mobile health-related apps. A…

Multiple Myeloma Patient Education Series (Part 4 of 5)

This summer I am sharing guest blogs from a variety of experts. This week’s blog is the fourth in a multi-part series about multiple myeloma from my colleague Dr. Margaret Henderson who has a Doctor of Pharmacy degree from the University of Colorado. –Dr. Stephen Vogt Welcome to the fourth installment in a 5-part patient…

Multiple Myeloma Patient Education Series (Part 3 of 5)

This summer I am sharing guest blogs from a variety of experts. This week’s blog is the third in a multi-part series about multiple myeloma from my colleague Dr. Margaret Henderson who has a Doctor of Pharmacy degree from the University of Colorado. –Dr. Stephen Vogt Welcome to the third installment in a 5-part patient…

Multiple Myeloma Patient Education Series (Part 2 of 5)

  This summer I am sharing guest blogs from a variety of experts. This week’s blog is the second in a multi-part series about multiple myeloma from my colleague Dr. Margaret Henderson who has a Doctor of Pharmacy degree from the University of Colorado. –Dr. Stephen Vogt Welcome to the second installment in a 5-part patient…